The Vector and Cell Processing Core (VCPC) was established as part of the Division of Gene Therapy and Regenerative Medicine (GTRM) at the WaNPRC.
The VCPC offers vector-based gene therapy resources for a range of nonhuman primate studies. This core also develops new technologies, platforms and reagents to improve vector production and modification of diverse nonhuman primate cell types.
VCPC provides:
- Viral vectors
- Viral titer assessment
- Pre-validated control vectors and assays to detect virus replication
- Ready-to-use nonhuman primate cells
- Gene-modified cell products for T cell and stem cell applications
